Clinical and Genetic Analysis of ROP
NCT04420156
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
Retinopathy of Prematurity (ROP) is a vascular disease affecting the retinas (back of the eye) of low birth weight infants. Although it can be treated effectively if diagnosed early, it continues to be a leading cause of childhood blindness in the United States and throughout the world. The investigators feel that this study will result in specific knowledge discovery about ROP, as well as general knowledge about how image-based data and genetic data can be combined to better understand clinical disease.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Retinopathy of Prematurity
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Up to 1 year
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Oregon Health and Science University
- Last updated on ClinicalTrials.gov
- April 20, 2022
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- University of Illinois Chicago · Chicago, IL
Michigan · 1
- William Beaumont Hospital · Royal Oak, MI
Oregon · 1
- Oregon Health & Science University · Portland, OR
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.